The importance of surgical therapy with expansion of TAVR to low‐risk patients

• Published in: Journal of cardiac surgery Vol. 34; no. 12; pp. 1432 - 1433
• Main Authors: Quimby, Donald L., Brown, Garrett, Belli, Erol V., Mohanty, Bibhu D.
• Format: Journal Article
• Language: English
• Published: United States 01-12-2019
• Subjects: aorta and great vessels; cardiovascular pathology; cardiovascular research; surgical history; aorta and great vessels; cardiovascular pathology; cardiovascular research; surgical history
• ISSN: 0886-0440; 1540-8191
• DOI: 10.1111/jocs.14282

Despite the landmark release of recent transcatheter aortic valve replacement data, the gold standard of surgical therapy is here to stay. Surgery remains vital in patient populations with low coronary height raising risk of coronary occlusion, aneurysmal ascending aorta, isolated aortic regurgitation, noncalcific disease, bicuspid valves, and multivessel coronary disease, or other structural abnormality requiring cardiac surgery. Consideration of these issues highlights the ongoing importance of multidisciplinary consideration of individual patient cases, careful review of imaging, and preservation of a robust surgical program to complement transcatheter development. As the landscape of valvular heart disease management continues to evolve, the surgeon's role is changing, but by no means diminished and their engagement in heart team decision making remains paramount.